BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19915630)

  • 1. Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD.
    Kim DY; Lee JH; Lee JH; Kim SH; Lim SN; Kim SD; Choi Y; Lee YS; Kang YA; Kang SI; Seol M; Ryu SG; Lee KH
    Bone Marrow Transplant; 2010 Jul; 45(7):1174-80. PubMed ID: 19915630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of NIH consensus criteria for chronic graft-versus-host disease.
    Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
    Leukemia; 2009 Jan; 23(1):78-84. PubMed ID: 18830253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.
    Jagasia M; Giglia J; Chinratanalab W; Dixon S; Chen H; Frangoul H; Engelhardt B; Goodman S; Greer J; Kassim A; Morgan D; Ruffner K; Schuening F
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1207-15. PubMed ID: 17889358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications.
    Del Fante C; Scudeller L; Viarengo G; Bernasconi P; Perotti C
    Transfusion; 2012 Sep; 52(9):2007-15. PubMed ID: 22320219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New classification of chronic GVHD: added clarity from the consensus diagnoses.
    Arora M; Nagaraj S; Witte J; DeFor TE; MacMillan M; Burns LJ; Weisdorf DJ
    Bone Marrow Transplant; 2009 Jan; 43(2):149-53. PubMed ID: 18794869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria.
    Ayuk F; Veit R; Zabelina T; Bussmann L; Christopeit M; Alchalby H; Wolschke C; Lellek H; Bacher U; Zander AR; Kröger N
    Ann Hematol; 2015 Oct; 94(10):1727-32. PubMed ID: 26204824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD).
    Elad S; Zeevi I; Or R; Resnick IB; Dray L; Shapira MY
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):62-9. PubMed ID: 19733252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NIH consensus criteria for chronic graft-versus-host disease: far more than just another classification.
    Socié G
    Leukemia; 2009 Jan; 23(1):1-2. PubMed ID: 19142188
    [No Abstract]   [Full Text] [Related]  

  • 10. [Classification of chronic graft-versus-host disease].
    Caballero Velázquez T; Pérez Simón JA
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():65-8. PubMed ID: 21381291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and manifestations of chronic graft-versus-host disease.
    Filipovich AH
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):251-7. PubMed ID: 18503990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation.
    Sohn SK; Kim DH; Baek JH; Kim JG; Lee KB; Lee KH; Lee JH; Choi SJ; Lee JH; Shin IH
    Bone Marrow Transplant; 2006 Apr; 37(7):699-708. PubMed ID: 16501588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice.
    Greinix HT; Loddenkemper C; Pavletic SZ; Holler E; Socié G; Lawitschka A; Halter J; Wolff D
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):167-75. PubMed ID: 20691801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
    Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
    Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease.
    Aisa Y; Mori T; Kato J; Yamane A; Kohashi S; Kikuchi T; Okamoto S
    Int J Hematol; 2013 Feb; 97(2):263-71. PubMed ID: 23371545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral chronic graft-versus-host disease scoring using the NIH consensus criteria.
    Treister NS; Stevenson K; Kim H; Woo SB; Soiffer R; Cutler C
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):108-14. PubMed ID: 19772943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center series.
    Tecchio C; Mosna F; Andreini A; Paoli L; Di Bella R; de Sabata D; Sorio M; Pizzolo G; Benedetti F
    Leuk Lymphoma; 2013 May; 54(5):1020-7. PubMed ID: 23035648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria.
    Sato T; Ichinohe T; Kanda J; Yamashita K; Kondo T; Ishikawa T; Uchiyama T; Takaori-Kondo A
    Int J Hematol; 2011 Apr; 93(4):532-541. PubMed ID: 21465116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to first flare-up episode of GVHD can stratify patients according to their prognosis during clinical course of progressive- or quiescent-type chronic GVHD.
    Kim DH; Sohn SK; Baek JH; Lee KH; Lee JH; Choi SJ; Shin IH
    Bone Marrow Transplant; 2007 Oct; 40(8):779-84. PubMed ID: 17700602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation.
    Atsuta Y; Suzuki R; Yamamoto K; Terakura S; Iida H; Kohno A; Naoe T; Yano K; Wakita A; Taji H; Hamaguchi M; Kodera Y; Sao H; Morishima Y; Hamajima N; Morishita Y
    Bone Marrow Transplant; 2006 Feb; 37(3):289-96. PubMed ID: 16400341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.